Results 71 to 80 of about 5,062,336 (201)

Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter

Asian Journal of Andrology, 2014
Radioiodine therapy, the most effective form of systemic radiotherapy available, is currently useful only for thyroid cancer because of the thyroid-specific expression of the human sodium iodide symporter (hNIS).
Xiao-Feng Gao, Tie Zhou, Guang-Hua Chen, Chuan-Liang Xu, Ye-Lei Ding, Ying-Hao Sun   +5 more
doaj   +1 more source

Predictive value of SPECT/CT after radioiodine therapy in differentiated thyroid cancer [PDF]

, 2016
Szabina Szujó, Erzsébet Schmidt, Zsuzsanna Szabó, Sarolta Szekeres, Katalin Zámbó, Emese Mezősi   +5 more
openalex   +1 more source

Focal Bronchiectasis Causing Abnormal Pulmonary Radioiodine Uptake in a Patient with Well-Differentiated Papillary Thyroid Carcinoma

Case Reports in Endocrinology, 2012
Background. False-positive pulmonary radioactive iodine uptake in the followup of differentiated thyroid carcinoma has been reported in patients with certain respiratory conditions. Patient Findings.
Ash Gargya, Elizabeth Chua
doaj   +1 more source

Therapy-related myeloid neoplasms following treatment with radioiodine

Haematologica, 2012
Background Few data are available on therapy-related myelodysplastic syndromes and acute myeloid leukemia developing after radioiodine treatment.Design and Methods We retrospectively analyzed 39 patients with myeloid neoplasms following radioiodine ...
Thomas Schroeder, Andrea Kuendgen, Sabine Kayser, Nicolaus Kröger, Friederike Braulke, Uwe Platzbecker, Viola Klärner, Fabian Zohren, Detlef Haase, Michael Stadler, Richard Schlenk, Akos G. Czibere, Ingmar Bruns, Roland Fenk, Norbert Gattermann, Rainer Haas, Guido Kobbe, Ulrich Germing   +17 more
doaj   +1 more source

Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma

BMC Research Notes
Differentiated thyroid cancer is the most common endocrinological malignancy. Radioiodine treatment has a clear benefit in locally aggressive and metastatic cancers. There are discussions about long-term and acute adverse events.
Barbora Havlínová, Ilona Součková, Kateřina Kopřivová, Jiří Doležal   +3 more
doaj   +1 more source

Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves’ disease patients [PDF]

, 2021
Maria Listewnik, Hanna Piwowarska-Bilska, Krystyna Jasiakiewicz, Bożena Birkenfeld   +3 more
openalex   +1 more source

Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear Medicine

, 2022
Matthias Schmidt, Peter Bartenstein, Jan Bucerius, Markus Dietlein, Alexander Drzezga, Ken Herrmann, Constantin Lapa, Kerstin Lorenz, Thomas J. Musholt, James Nagarajah, Christoph Reiners, Carsten Oliver Sahlmann, Michael C. Kreißl   +12 more
openalex   +2 more sources

Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer

Biologics: Targets & Therapy, 2008
Bernadette Biondi, Melania Pulcrano, Loredana Pagano, Gaetano LombardiDepartment of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Naples, ItalyAbstract: Various studies have demonstrated the safety and ...
Bernadette Biondi, Melania Pulcrano, Loredana Pagano, Gaetano Lombardi   +3 more
doaj  

Radioiodine-Valuable Addition to Therapy of Glioblastoma Muliforme [PDF]

, 2023
Agata Czarnywojtek
openalex   +1 more source

High dose Radioiodine Therapy Preceded by Fertility Preservation Surgery in Metastatic Malignant Struma Ovarii

, 2022
Shagos Gopalannair Santhamma, Valam Puthussery Vipin, Jem Kalathil, Nita Mary John   +3 more
openalex   +2 more sources